Therefore, exogenous supplements may be needed
Reactive oxygen and nitrogen species (Ros/rns) scavenging assays, oxidative stress biomarkers, and chromatographic/chemometric assays
For those on antidiabetic medications, such as insulin or oral hypoglycemic agents, glutathione may alter the efficacy of these drugs, potentially leading to hypo- or hyperglycemia
The global market for nasal drug delivery in patients was valued at approximately $85.89 billion in 2025 and is projected to reach $119.56 billion by 2029 at a compound annual growth rate (CAGR) of 8.6% (The Business Research Company, 2025)
Our supplements contain no ingredients of animal origin
In 2019, the United States Food and Drug Administration (FDA) documented adverse events in seven patients who received intravenous injections containing L-glutathione 200mg/mL compounded by a pharmacy using L-glutathione